Myrcia loranthifolia
Myrcia loranthifolia · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Myrcia loranthifolia is a botanical species that has gained significant scientific interest due to its diverse therapeutic potential. Research focusing on various preparations, including aqueous, ethanol, and hexane leaf extracts, has revealed a rich profile of bioactive compounds. These leaves are notably abundant in condensed tannins, flavonoids, and polyphenols, which contribute to their medicinal properties. Studies have demonstrated that these extracts exhibit potent antileukemic and antimicrobial activities, particularly against pathogens like Pseudomonas aeruginosa. Furthermore, the plant shows promise in mitigating the harmful effects of oxidative stress within biological systems.
- Synonyms
- Calyptranthes Mutabilis · Calyptranthes Grandifolia Var. Macrantha · 28 more
- Common names
- Not available
- Family
- Myrtaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Myrcia loranthifolia is a versatile plant known by a diverse array of local names depending on the region. It is frequently referred to as Brasa-viva or Guamirim, reflecting its widespread recognition in various habitats. Some communities also identify the species as Guamirim-araçá or Guamirim-chorão to distinguish its specific characteristics. Additionally, it is commonly called Uvá-de-facho, adding to the rich linguistic variety associated with the species. These multiple common names highlight the deep cultural and botanical connections people have with this plant.
Sources: Catalogue of Life (COL)
Synonyms
Myrcia loranthifolia is a botanical subject characterized by a complex web of taxonomic synonyms. Within scientific literature, this species is frequently identified as Calyptranthes brasiliensis. This relationship extends to several specific varieties, including the forms known as var. densa, var. laxa, and var. mutabilis. Furthermore, the plant has been historically linked to the name Calyptranthes dardanoi in various classifications. Understanding these overlapping designations is essential for accurate identification and botanical study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Myrcia loranthifolia is a distinct member of the kingdom Plantae. This species is classified under the class Equisetopsida, reflecting its fundamental biological structure. Within this framework, it belongs to the order Myrtales, which helps define its evolutionary lineage. It is further categorized into the family Myrtaceae, a group known for its diverse botanical characteristics. Ultimately, this plant is a specialized representative of the genus Myrcia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Myrtaceae |
| Genus | Myrcia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Myrcia loranthifolia is a botanical species primarily found across the vast landscapes of Southern America. Within this region, its presence is particularly notable throughout the diverse territories of Brazil. The plant maintains a widespread distribution that encompasses the Northeast portion of the country. Additionally, it can be found thriving in the various environments of Brazil's South. Its range further extends into the Southeast, illustrating a significant ecological footprint across the Brazilian landscape.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Myrcia loranthifolia is a robust tree characterized by its sturdy, self-supporting growth form. This species typically reaches impressive dimensions, with a height that generally ranges between 10 and 15 meters. However, some specimens may be found at a more modest minimum height of 5 meters. Regardless of its specific size, the plant maintains a commanding presence in its natural habitat. Its structural stability makes it a notable feature within its ecological community.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Myrcia loranthifolia, also known as Calyptranthes grandifolia, shows significant promise as a source of bioactive natural products. Recent studies on its aqueous leaf extract have highlighted its dual potential in combating various biological threats. Specifically, the plant has demonstrated notable antimicrobial activity, particularly through its inhibitory effects against Pseudomonas aeruginosa. Furthermore, the extract exhibits antileukemic properties by producing cytotoxicity in leukemia cell lines like HL60 and Kasumi-1. These findings suggest that the plant's high concentration of polyphenols and flavonoids may play a crucial role in its therapeutic effectiveness.
Compounds
Myrcia loranthifolia, also known as Calyptranthes grandifolia, serves as a promising natural source of diverse bioactive molecules. Scientific analysis of its aqueous leaf extract reveals a complex chemical profile rich in essential phytoconstituents. Specifically, the plant contains significant amounts of condensed tannins and flavonoids. Furthermore, the extract is characterized by a high quantity of polyphenols, which contribute to its biological potential. These findings suggest that the species may hold great value in the development of new antimicrobial and antileukemic treatments.
Conditions
Myrcia loranthifolia possesses therapeutic potential by treating 6-OHDA-induced cell damage and 6-hydroxydopamine-induced neurotoxicity. It also serves to treat 6-OHDA-induced cell death within biological systems. Furthermore, this plant is effective in treating JNK3 to mitigate neurodegenerative-related enzymatic activity. Finally, Myrcia loranthifolia demonstrates antimicrobial properties by treating Pseudomonas aeruginosa.
Preparations
Myrcia loranthifolia is prepared as aqueous leaf extract to investigate its antimicrobial and antileukemic biological potential. The plant is also prepared as ethanol leaf extracts to examine its inhibitory activity against specific enzymes and oxidative stress. Additionally, Myrcia loranthifolia is prepared as hexane leaf extracts to assess its ability to prevent neurotoxicity. These various extraction methods allow for the study of different bioactive properties within the species. Each preparation method serves a specific role in determining the plant's medicinal efficacy in vitro.
Parts used
Myrcia loranthifolia possesses specific morphological characteristics, such as having the leaf as a distinct part of its structure. While research on this specific species is ongoing, related members of the Myrtaceae family have demonstrated significant biological potential. For instance, studies on Calyptranthes grandifolia show that leaf extracts can provide neuroprotective effects against certain types of neurotoxicity. Furthermore, these aqueous extracts have exhibited promising antimicrobial and antileukemic activities in laboratory settings. Such findings highlight how the diverse components of these plants serve as vital sources for developing new therapeutic molecules.